Published in
Elsevier, Revue Neurologique, 10(178), p. 1011-1030, 2022
DOI: 10.1016/j.neurol.2022.06.012
Links
Tools
High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 